| Schedule of Share Based Compensation Options Awarded |
Schedule
of Share Based Compensation Options Awarded
| | |
For the three-month period ended | |
| | |
March 31, 2025 | | |
March 31, 2024 | |
| | |
Weighted average
of exercise price | | |
Number
of options | | |
Weighted average
of exercise price | | |
Number
of options | |
| Outstanding as of the beginning of the period | |
$ | 0.51 | | |
| 15,072,175 | | |
$ | 0.42 | | |
| 15,544,175 | |
| Granted | |
$ | - | | |
| - | | |
$ | - | | |
| - | |
| Forfeited | |
$ | 0.58 | | |
| (150,000 | ) | |
$ | 0.32 | | |
| (1,447,500 | ) |
| Outstanding as of the end of period | |
$ | 0.44 | | |
| 14,922,175 | | |
$ | 0.42 | | |
| 14,096,675 | |
|
Schedule
of Share Based Compensation Options Awarded
| | |
2024 | |
2023 |
| | |
Weighted average of exercise price | |
Number of
options | |
Weighted average of exercise price | |
Number of
options |
| Outstanding as of the beginning of the year | |
$ | 0.42 | | |
| 15,544,175 | | |
$ | 0.4 | | |
| 13,943,842 | |
| Granted | |
$ | 0.55 | | |
| 1,715,500 | | |
$ | 0.58 | | |
| 2,467,000 | |
| Forfeited | |
$ | 0.39 | | |
| (1,500,000 | ) | |
$ | 0.32 | | |
| (866,667 | ) |
Expired | |
$ | 0.28 | | |
| (687,500 | ) | |
| | | |
| - | |
| Outstanding as of the end of year | |
$ | 0.42 | | |
| 15,072,175 | | |
$ | 0.42 | | |
| 15,544,175 | |
|
| Schedule of Stock-Based Compensation Expenses |
The
stock-based compensation expenses for the three months ended March 31, 2025 and March 31, 2024 were recognized in the statements of operations
as follows;
Schedule
of Stock-Based Compensation Expenses
| | |
March
31, 2025 | | |
March
31, 2024 | |
| | |
For the three-month period ended | |
| | |
March 31, 2025 | | |
March 31, 2024 | |
| | |
US Dollars (In thousands) | |
| | |
| | |
| |
| Research and development expenses | |
| 7 | | |
| 23 | |
| Marketing expenses | |
| 1 | | |
| 162 | |
| General and administrative expenses | |
| 46 | | |
| 21 | |
| | |
| | | |
| | |
| Total
stock-based compensation | |
| 54 | | |
| 206 | |
|
Schedule
of Stock-Based Compensation Expenses
| | |
2024 | |
2023 |
| | |
Year ended December 31 |
| | |
2024 | |
2023 |
| | |
US Dollars (In thousands) |
| Research and development expenses | |
| 43 | | |
| 158 | |
| Marketing expenses | |
| 215 | | |
| 659 | |
| General and administrative expenses | |
| 227 | | |
| 865 | |
| | |
| | | |
| | |
| Total stock-based compensation | |
| 485 | | |
| 1,682 | |
|